Tarsier Pharma
Business Services · Israel · 1-10 Employees
View Company Info for Free
Overview
Headquarters
10 Hama'apilim St, Zichron Yaacov, 30937...Phone Number
+972 46398050Website
www.tarsierpharma.comRevenue
-Industry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Tarsier Pharma
Tarsier Pharma is a late clinical-stage biopharmaceutical company developing bio-inspired therapies for autoimmune and inflammatory eye diseases that can threaten vision. Its lead programs focus on steroid-free treatments for ocular conditions such as anterior uveitis, with a proprietary platform designed to modulate immune responses and preserve sight through innovative ophthalmic drug development.Explore more
Tarsier Pharma Org Chart
RN
Chief Marketing Officer
AG
Chief Financial Officer
JB
Chief Financial Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Tarsier Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Tarsier Pharma had a recent Job posting/layoffs
Tarsier Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Tarsier Pharma has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Tarsier Pharma has new funding data
Check out if Tarsier Pharma is spiking on competitors!
Product Launch: Get notified when Tarsier Pharma launches new products
Earning: See what the market has to say on Tarsier Pharma recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Tarsier Pharma
Recommended Actions
Find VP level buyers at Tarsier Pharma
Find 3 more new buyers
Company Profile Activity
Activity Insights
Tarsier Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Tarsier Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Tarsier Pharma.
Tarsier Pharma Tech Stack
A closer look at the technologies used by Tarsier Pharma
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
Tarsier Pharma News & Media
Tarsier Pharma Appoints Ashley Kline as Chief Commercial Officer, Expanding Its U.S. Presence
Ms. Kline Brings Over 15 Years of Biopharmaceutical Experience in Ophthalmology to the Growing Tarsier Leadership Team TEL-AVIV, Israel, Jan. 7, 2025 /PRNewswire/ -- Tarsier Pharma®, Ltd, a late-clinical stage ophthalmic biopharmaceutical company focused on developing and commercializing...Tarsier Pharma Announces the Appointment of Emilee Fulcher as Vice President of Clinical Affairs
TEL-AVIV, Israel, May 28, 2024 /PRNewswire/ -- Tarsier Pharma, Ltd, a late-stage ophthalmic biopharmaceutical company focused on developing and commercializing first-in-class new therapies for the treatment of blinding ocular diseases proudly announces the appointment of Emilee Fulcher as...Tarsier Pharma Receives FDA Agreement Under Special Protocol Assessment (SPA) for Tarsier-04 Phase 3 Trial of TRS01 Ophthalmic Solution for the Treatment of Non-infectious Uveitis including Uveitic Glaucoma
TEL AVIV, Israel , Jan. 16, 2024 /PRNewswire/ -- Tarsier Pharma, Ltd., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing first-in-class new therapies for the treatment of blinding ocular diseases, today announced it has received agreement from...Tarsier Pharma Announces Successful Type C Meeting with FDA for TRS01 in Noninfectious Uveitis
Agreement on registrational program's primary and key secondary Endpoint to reflect TRS01 positive risk/benefit profile for patients with noninfectious uveitis and uveitic glaucoma TRS01 has the potential to be the first line treatment option for noninfectious uveitis and specifically...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Tarsier Pharma
Sign Up For FreeTo access detailed company insights
Tarsier Pharma is a late clinical-stage biopharmaceutical company developing bio-inspired therapies for autoimmune and inflammatory eye diseases that can threaten vision. Its lead programs focus on steroid-free treatments for ocular conditions such as anterior uveitis, with a proprietary platform designed to modulate immune responses and preserve s... Read More
